PEDF expression is inhibited by insulin treatment in adipose tissue via suppressing 11β-HSD1.

Early intensive insulin therapy improves insulin sensitivity in type 2 diabetic patients; while the underlying mechanism remains largely unknown. Pigment epithelium-derived factor (PEDF), an anti-angiogenic factor, is believed to be involved in the pathogenesis of insulin resistance. Here, we hypoth...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yinli Zhou, Fen Xu, Hongrong Deng, Yan Bi, Weiping Sun, Yi Zhao, Zonglan Chen, Jianping Weng
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
R
Q
Acceso en línea:https://doaj.org/article/1a5c4e9e26d34b8180427fb9fbe82fea
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1a5c4e9e26d34b8180427fb9fbe82fea
record_format dspace
spelling oai:doaj.org-article:1a5c4e9e26d34b8180427fb9fbe82fea2021-11-18T08:41:15ZPEDF expression is inhibited by insulin treatment in adipose tissue via suppressing 11β-HSD1.1932-620310.1371/journal.pone.0084016https://doaj.org/article/1a5c4e9e26d34b8180427fb9fbe82fea2013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24367624/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203Early intensive insulin therapy improves insulin sensitivity in type 2 diabetic patients; while the underlying mechanism remains largely unknown. Pigment epithelium-derived factor (PEDF), an anti-angiogenic factor, is believed to be involved in the pathogenesis of insulin resistance. Here, we hypothesize that PEDF might be down regulated by insulin and then lead to the improved insulin resistance in type 2 diabetic patients during insulin therapy. We addressed this issue by investigating insulin regulation of PEDF expression in diabetic conditions. The results showed that serum PEDF was reduced by 15% in newly diagnosed type 2 diabetic patients after insulin therapy. In adipose tissue of diabetic Sprague-Dawley rats, PEDF expression was associated with TNF-α elevation and it could be decreased both in serum and in adipose tissue by insulin treatment. In adipocytes, PEDF was induced by TNF-α through activation of NF-κB. The response was inhibited by knockdown and enhanced by over expression of NF-κB p65. However, PEDF expression was indirectly, not directly, induced by NF-κB which promoted 11β-hydroxysteroid dehydrogenase 1 (11β-HSD1) expression in adipocytes. 11β-HSD1 is likely to stimulate PEDF expression through production of active form of glucocorticoids as dexamethasone induced PEDF expression in adipose tissue. Insulin inhibited PEDF by down-regulating 11β-HSD1 expression. The results suggest that PEDF activity is induced by inflammation and decreased by insulin through targeting 11β-HSD1/glucocorticoid pathway in adipose tissue of diabetic patients.Yinli ZhouFen XuHongrong DengYan BiWeiping SunYi ZhaoZonglan ChenJianping WengPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 12, p e84016 (2013)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Yinli Zhou
Fen Xu
Hongrong Deng
Yan Bi
Weiping Sun
Yi Zhao
Zonglan Chen
Jianping Weng
PEDF expression is inhibited by insulin treatment in adipose tissue via suppressing 11β-HSD1.
description Early intensive insulin therapy improves insulin sensitivity in type 2 diabetic patients; while the underlying mechanism remains largely unknown. Pigment epithelium-derived factor (PEDF), an anti-angiogenic factor, is believed to be involved in the pathogenesis of insulin resistance. Here, we hypothesize that PEDF might be down regulated by insulin and then lead to the improved insulin resistance in type 2 diabetic patients during insulin therapy. We addressed this issue by investigating insulin regulation of PEDF expression in diabetic conditions. The results showed that serum PEDF was reduced by 15% in newly diagnosed type 2 diabetic patients after insulin therapy. In adipose tissue of diabetic Sprague-Dawley rats, PEDF expression was associated with TNF-α elevation and it could be decreased both in serum and in adipose tissue by insulin treatment. In adipocytes, PEDF was induced by TNF-α through activation of NF-κB. The response was inhibited by knockdown and enhanced by over expression of NF-κB p65. However, PEDF expression was indirectly, not directly, induced by NF-κB which promoted 11β-hydroxysteroid dehydrogenase 1 (11β-HSD1) expression in adipocytes. 11β-HSD1 is likely to stimulate PEDF expression through production of active form of glucocorticoids as dexamethasone induced PEDF expression in adipose tissue. Insulin inhibited PEDF by down-regulating 11β-HSD1 expression. The results suggest that PEDF activity is induced by inflammation and decreased by insulin through targeting 11β-HSD1/glucocorticoid pathway in adipose tissue of diabetic patients.
format article
author Yinli Zhou
Fen Xu
Hongrong Deng
Yan Bi
Weiping Sun
Yi Zhao
Zonglan Chen
Jianping Weng
author_facet Yinli Zhou
Fen Xu
Hongrong Deng
Yan Bi
Weiping Sun
Yi Zhao
Zonglan Chen
Jianping Weng
author_sort Yinli Zhou
title PEDF expression is inhibited by insulin treatment in adipose tissue via suppressing 11β-HSD1.
title_short PEDF expression is inhibited by insulin treatment in adipose tissue via suppressing 11β-HSD1.
title_full PEDF expression is inhibited by insulin treatment in adipose tissue via suppressing 11β-HSD1.
title_fullStr PEDF expression is inhibited by insulin treatment in adipose tissue via suppressing 11β-HSD1.
title_full_unstemmed PEDF expression is inhibited by insulin treatment in adipose tissue via suppressing 11β-HSD1.
title_sort pedf expression is inhibited by insulin treatment in adipose tissue via suppressing 11β-hsd1.
publisher Public Library of Science (PLoS)
publishDate 2013
url https://doaj.org/article/1a5c4e9e26d34b8180427fb9fbe82fea
work_keys_str_mv AT yinlizhou pedfexpressionisinhibitedbyinsulintreatmentinadiposetissueviasuppressing11bhsd1
AT fenxu pedfexpressionisinhibitedbyinsulintreatmentinadiposetissueviasuppressing11bhsd1
AT hongrongdeng pedfexpressionisinhibitedbyinsulintreatmentinadiposetissueviasuppressing11bhsd1
AT yanbi pedfexpressionisinhibitedbyinsulintreatmentinadiposetissueviasuppressing11bhsd1
AT weipingsun pedfexpressionisinhibitedbyinsulintreatmentinadiposetissueviasuppressing11bhsd1
AT yizhao pedfexpressionisinhibitedbyinsulintreatmentinadiposetissueviasuppressing11bhsd1
AT zonglanchen pedfexpressionisinhibitedbyinsulintreatmentinadiposetissueviasuppressing11bhsd1
AT jianpingweng pedfexpressionisinhibitedbyinsulintreatmentinadiposetissueviasuppressing11bhsd1
_version_ 1718421430625894400